MLC1 and benign prostatic hyperplasia: Generally, novel targets and compounds with impacts on actin organization or myosin light chain (MLC) phosphorylation may be considered in the context of BPH, as actin organization is an essential prerequisite for smooth muscle contraction and proliferation, and MLC phosphorylation is required for smooth muscle contraction (Hennenberg et al., 2014).